Synapse News
Fusion Pharmaceuticals to be acquired by AstraZeneca, accelerating development of next-generation radioconjugates to treat cancer
Hamilton-based Fusion Pharmaceuticals Inc. has entered into a definitive agreement to be acquired by AstraZeneca.
OBIO® Celebrates the Advancement of Women in Health Science with WiHI Seed Program and Leadership Awards
11 women-led companies have been selected for the OBIO® WiHI Seed Program.
Innovation Factory celebrates Hamilton’s growing life sciences network and SOPHIE program recipients
The Molecules and Masterpieces event showcased the SOPHIE program’s role as a catalyst for life science partnerships, commercialization and innovation.
Topology Health toolkit integrates digital health applications
Topology Health is testing their AI-powered toolkit that helps healthcare providers integrate digital health apps for efficient data flow.
From ideation to commercialization, Cosm’s journey in advancing women’s pelvic health as it enters the Canadian market and beyond!
Femtech startup Cosm Medical is changing women's pelvic health with a medical device that combines software, AI and 3D printing.
Innovation Factory Expands Support for High-Potential Life Science Innovators by Introducing Medtech Manufacturing Funding Program
With support from the Government of Canada, Innovation Factory launches the Canadian Medtech Alliance (CAMEDA) program.
2022 Synapse Cluster Report: A Year of Breakthroughs and Boundless Possibilities for Hamilton’s Life Sciences Cluster
The 2022 Cluster Report summarizes the dynamic growth of the Hamilton life sciences ecosystem, highlighting the integration of organizations that contribute to its vibrant community.
Innovation Factory partners with HaloHealth to bridge the gap between healthcare startups and clinical expertise
Innovation Factory announces an MOU with HaloHealth to deliver a collaborative medical assessment & physician advisory service to SOPHIE companies.
Altis Labs to Develop Digital Twins for Clinical Trials in Partnership with Leading Research Institutions and Global Biopharmaceutical Companies
Altis Labs announces today that it is leading an international coalition focused on the development and implementation of digital twins in clinical trials.